TREATMENT OF DISORDERS BY REACTION OF HYPERSENSITIVITY.

摘要

Use of a portion of modified mammalian blood, a portion of blood that has been modified extracorporeally by exposure, simultaneously or sequentially, to the stressor of an oxidative environment, and of UV radiation, for the manufacture of a medicament for treatment or prophylaxis of delayed-type hypersensitivity diseases, mediated by T cell, in a mammalian patient.